Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Constellation Pharmaceuticals Inc (CNST)

Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,628,631
  • Shares Outstanding, K 47,915
  • Annual Sales, $ 0 K
  • Annual Income, $ -126,360 K
  • 60-Month Beta 2.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.32
Trade CNST with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.34
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.89
  • Number of Estimates 5
  • High Estimate -0.87
  • Low Estimate -0.91
  • Prior Year -0.70
  • Growth Rate Est. (year over year) -27.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.65 +1.01%
on 06/25/21
34.05 -0.18%
on 07/14/21
+0.29 (+0.86%)
since 06/14/21
3-Month
18.82 +80.61%
on 05/13/21
34.05 -0.18%
on 07/14/21
+10.91 (+47.27%)
since 04/14/21
52-Week
17.00 +99.94%
on 09/24/20
39.30 -13.51%
on 01/20/21
+5.43 (+19.01%)
since 07/14/20

Most Recent Stories

More News
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology

Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma PLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 15, 2021 / MorphoSys AG (FSE:MOR;...

MOR : 18.96 (+2.43%)
CNST : 33.99 (+0.06%)
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals

MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust...

MOR : 18.96 (+2.43%)
CNST : 33.99 (+0.06%)
Lifshitz Law Firm, P.C. Announces Investigation of CNST, FFWM, SLCT, and GRA

NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) --

CNST : 33.99 (+0.06%)
FFWM : 7.20 (+5.73%)
SLCT : 18.88 (-2.43%)
GRA : 69.99 (+0.03%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, LDL, IKNX, CNST; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RAVN : 58.08 (+0.19%)
LDL : 62.09 (+0.02%)
IKNX : 33.90 (-0.29%)
CNST : 33.99 (+0.06%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CORE, MMAC, CNST, SLCT; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 28, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Core-Mark Holding Company, Inc. (NASDAQ:CORE) concerning...

CORE : 45.65 (-0.76%)
MMAC : 27.77 (+0.04%)
CNST : 33.99 (+0.06%)
SLCT : 18.88 (-2.43%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates EBSB, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Meridian Bancorp, Inc. (NASDAQ:EBSB) concerning potential...

EBSB : 24.15 (-2.03%)
FMBI : 21.51 (+2.77%)
CNST : 33.99 (+0.06%)
SLCT : 18.88 (-2.43%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, FMBI, SLCT, and CNST Shareholders About Its Ongoing Investigations

NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) --

KIN : 9.25 (+0.11%)
ELAN : 14.37 (-1.03%)
FMBI : 21.51 (+2.77%)
SLCT : 18.88 (-2.43%)
CNST : 33.99 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Constellation Pharmaceuticals, Inc. (NASDAQ:CNST)...

CNST : 33.99 (+0.06%)
MDP : 59.07 (+0.12%)
FMBI : 21.51 (+2.77%)
AVCO : 0.5259 (-16.52%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of CNST, USCR, SVBI, and QTS Buyouts

WILMINGTON, Del., June 17, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

CNST : 33.99 (+0.06%)
USCR : 73.99 (-0.01%)
SVBI : 13.63 (+5.66%)
QTS : 77.98 (+0.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KIN, CNST, MDP, FMBI; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

KIN : 9.25 (+0.11%)
CNST : 33.99 (+0.06%)
MDP : 59.07 (+0.12%)
FMBI : 21.51 (+2.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company's lead product candidates consists of CPI-1205, which inhibits enhancer of zeste homolog 2 and...

See More

Key Turning Points

3rd Resistance Point 34.12
2nd Resistance Point 34.08
1st Resistance Point 34.04
Last Price 33.99
1st Support Level 33.96
2nd Support Level 33.92
3rd Support Level 33.88

See More

52-Week High 39.30
Last Price 33.99
Fibonacci 61.8% 30.78
Fibonacci 50% 28.15
Fibonacci 38.2% 25.52
52-Week Low 17.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar